EMA Panel Backs Linzagolix for Uterine Fibroid Symptoms

Linzagolix is an oral gonadotropin-releasing hormone antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
International Approvals

source https://www.medscape.com/viewarticle/965129?src=rss